RJA
CC icon

Raymond James & Associates’s Chemours CC Stock Holding History

Raymond James & Associates’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.96M Buy
96,215
+64,190
+200% +$1.31M ﹤0.01% 2241
2024
Q2 		$723K Sell
32,025
-2,640
-8% -$69.1K ﹤0.01% 2842
2024
Q1 		$910K Buy
34,665
+759
+2% +$21.6K ﹤0.01% 2657
2023
Q4 		$1.07M Sell
33,906
-50,782
-60% -$1.38M ﹤0.01% 2474
2023
Q3 		$2.38M Sell
84,688
-7,336
-8% -$252K ﹤0.01% 1911
2023
Q2 		$3.39M Sell
92,024
-9,423
-9% -$288K ﹤0.01% 1733
2023
Q1 		$3.04M Buy
101,447
+1,589
+2% +$52.3K ﹤0.01% 1792
2022
Q4 		$3.06M Sell
99,858
-2,780
-3% -$83.4K ﹤0.01% 1734
2022
Q3 		$2.53M Buy
102,638
+1,313
+1% +$43.3K ﹤0.01% 1824
2022
Q2 		$3.24M Sell
101,325
-34,292
-25% -$1.26M ﹤0.01% 1692
2022
Q1 		$4.27M Buy
135,617
+32,121
+31% +$1M ﹤0.01% 1618
2021
Q4 		$3.47M Buy
103,496
+45,344
+78% +$1.41M ﹤0.01% 1790
2021
Q3 		$1.69M Sell
58,152
-13,118
-18% -$425K ﹤0.01% 2220
2021
Q2 		$2.48M Sell
71,270
-2,333
-3% -$77.3K ﹤0.01% 1953
2021
Q1 		$2.05M Sell
73,603
-12,025
-14% -$320K ﹤0.01% 1992
2020
Q4 		$2.12M Buy
85,628
+13,702
+19% +$326K ﹤0.01% 1856
2020
Q3 		$1.5M Sell
71,926
-27,217
-27% -$525K ﹤0.01% 1937
2020
Q2 		$1.52M Buy
99,143
+14,691
+17% +$186K ﹤0.01% 1886
2020
Q1 		$749K Buy
84,452
+66,722
+376% +$962K ﹤0.01% 2162
2019
Q4 		$321K Buy
17,730
+2,341
+15% +$38.9K ﹤0.01% 3037
2019
Q3 		$230K Buy
15,389
+28
+0.2% +$455 ﹤0.01% 3172
2019
Q2 		$369K Sell
15,361
-46,873
-75% -$1.38M ﹤0.01% 2875
2019
Q1 		$2.31M Buy
62,234
+47,749
+330% +$1.74M ﹤0.01% 1672
2018
Q4 		$409K Sell
14,485
-2,534
-15% -$80.2K ﹤0.01% 2676
2018
Q3 		$671K Sell
17,019
-3,355
-16% -$147K ﹤0.01% 2498
2018
Q2 		$904K Sell
20,374
-95,947
-82% -$4.77M ﹤0.01% 2284
2018
Q1 		$5.67M Buy
116,321
+14,031
+14% +$701K 0.01% 1082
2017
Q4 		$5.12M Buy
102,290
+11,158
+12% +$584K 0.01% 1112
2017
Q3 		$4.61M Buy
91,132
+14,149
+18% +$667K 0.01% 1127
2017
Q2 		$2.92M Buy
76,983
+58,767
+323% +$2.32M 0.01% 1339
2017
Q1 		$701K Sell
18,216
-923
-5% -$27.8K ﹤0.01% 2188
2016
Q4 		$423K Sell
19,139
-8,598
-31% -$177K ﹤0.01% 2430
2016
Q3 		$444K Buy
27,737
+12,095
+77% +$138K ﹤0.01% 2364
2016
Q2 		$129K Sell
15,642
-14,502
-48% -$129K ﹤0.01% 2754
2016
Q1 		$211K Sell
30,144
-175,633
-85% -$883K ﹤0.01% 2545
2015
Q4 		$1.1M Buy
+205,777
New +$1.32M ﹤0.01% 1589

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Raymond James & Associates's CC Position: Q3 2024 in Review

Raymond James & Associates increased its Chemours (CC) stake by 200% in Q3 2024, buying an estimated $1.31M and bringing the position to 96,215 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2241.

Raymond James & Associates first reported a position in CC in Q4 2015 and has held it in 36 quarters since. The position peaked at $5.67M in Q1 2018. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.

  • Raymond James & Associates held 96,215 shares of Chemours worth $1.96M as of Q3 2024.
  • Raymond James & Associates bought 64,190 Chemours shares in Q3 2024, an estimated $1.31M.
  • Chemours made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2241 holding.
  • Raymond James & Associates first reported a position in Chemours in Q4 2015 and has held it in 36 quarters since.
  • Raymond James & Associates's Chemours position peaked at $5.67M in Q1 2018.
  • 421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.